{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:46:53Z","timestamp":1790786813752,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Plan Project of Sichuan Province","award":["2020YFS0035"],"award-info":[{"award-number":["2020YFS0035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A recent survey revealed that extensive off-label use of sugammadex in pediatric anesthesia deserved particular attention. The present study with trial sequential analysis (TSA) aimed to evaluate the effects of sugammadex for antagonizing neuromuscular blockade (NMB) in pediatric patients, and to investigate whether the findings achieved the required information size to draw conclusions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed, Embase, Cochrane Library and China National Knowledge Infrastructure (CNKI) were searched from inception to April 2021. All randomized controlled trials used sugammadex as reversal agent in pediatric patients were enrolled. Time from NMB reversal to recovery of the train-of-four ratio (TOFr) to 0.9 and extubation time were considered as co-primary outcomes, and incidences of adverse events were considered as secondary outcomes. Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was used to rate the quality of evidences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data from 18 studies involving 1,065 pediatric patients were acquired. The results revealed that use of sugammadex was associated with shorter duration from administration of reversal agents to TOFr\u2009&gt;\u20090.9 (MD\u2009=\u2009-14.42, with 95% CI [-17.08, -11.75]) and shorter interval from reversal from NMB to extubation (MD\u2009=\u2009-13.98, with 95% CI [-16.70, -11.26]) compared to control groups. TSA also indicated that the current sample sizes were sufficient with unnecessary further trials. Analysis of secondary outcomes indicated that administration of sugammadex was associated with less incidence of postoperative nausea and vomiting (PONV), bradycardia, and dry mouth compared to control groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Considering of satisfactory and rapid neuromuscular blockade reversal with low incidences of adverse events, sugammadex might be considered as the preferred option for children in clinical anesthesia practice compared to acetylcholinesterase inhibitors. However, overall low-quality evidences in present study rated by GRADE system indicated that superiority of sugammadex employed in pediatric patients needs to be confirmed by more studies with high quality and large sample size in future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-022-03288-0","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T06:02:34Z","timestamp":1652940154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Bingchen","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"3288_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1213\/ANE.0000000000002387","volume":"126","author":"GS Murphy","year":"2018","unstructured":"Murphy GS. Neuromuscular monitoring in the perioperative period. Anesth Analg. 2018;126:464\u20138.","journal-title":"Anesth Analg"},{"issue":"1","key":"3288_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1213\/ANE.0b013e3181da832d","volume":"111","author":"GS Murphy","year":"2010","unstructured":"Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111(1):120\u20138.","journal-title":"Anesth Analg"},{"issue":"345","key":"3288_CR3","doi-asserted-by":"publisher","first-page":"e6329","DOI":"10.1136\/bmj.e6329","volume":"15","author":"M Grosse-Sundrup","year":"2012","unstructured":"Grosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ. 2012;15(345):e6329. https:\/\/doi.org\/10.1136\/bmj.e6329.","journal-title":"BMJ"},{"key":"3288_CR4","first-page":"CD007362","volume":"4","author":"A Abrishami","year":"2009","unstructured":"Abrishami A, Ho J, Wong J, Yin L, Chung F. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database Syst Rev. 2009;4:CD007362.","journal-title":"Cochrane Database Syst Rev"},{"key":"3288_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0952-8180(95)00088-7","volume":"7","author":"H Kirkegaard-Nielsen","year":"1995","unstructured":"Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, B\u00fclow K. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block. J Clin Anesth. 1995;7:635\u20139.","journal-title":"J Clin Anesth"},{"key":"3288_CR6","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/BF03011807","volume":"43","author":"H Kirkegaard-Nielsen","year":"1996","unstructured":"Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Pedersen HS, Jensen EW. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade. Can J Anaesth. 1996;43:932\u20138.","journal-title":"Can J Anaesth"},{"issue":"2","key":"3288_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/1521-3773(20020118)41:2<265::AID-ANIE265>3.0.CO;2-Q","volume":"41","author":"A Bom","year":"2002","unstructured":"Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl. 2002;41(2):265\u201370.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3288_CR8","first-page":"19","volume":"29","author":"J Caldwell","year":"2011","unstructured":"Caldwell J. Sugammadex: past, present and future. Adv Anaesth. 2011;29:19\u201327.","journal-title":"Adv Anaesth"},{"issue":"6","key":"3288_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/bja\/87.6.912","volume":"87","author":"E Moore","year":"2001","unstructured":"Moore E, Hunter J. The new neuromuscular blocking agents: do they offer any advantages? Br J Anaesth. 2001;87(6):912\u201325.","journal-title":"Br J Anaesth"},{"issue":"4","key":"3288_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/00000542-200510000-00007","volume":"103","author":"F Gijsenbergh","year":"2005","unstructured":"Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology. 2005;103(4):695\u2013703.","journal-title":"Anesthesiology"},{"issue":"8","key":"3288_CR11","first-page":"CD012763","volume":"8","author":"AM Hristovska","year":"2017","unstructured":"Hristovska AM, Duch P, Allingstrup M, Afshari A. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev. 2017;8(8):CD012763.","journal-title":"Cochrane Database Syst Rev"},{"key":"3288_CR12","unstructured":"Merck.com. Highlights of prescribing information BRIDION\u00ae (sugammadex) Injection, for intravenous use Initial U.S. Approval. 2015. Available at: https:\/\/www.merck.com\/product\/usa\/pi_circulars\/b\/bridion\/bridion_pi.pdf. Accessed 24 Oct 2020"},{"issue":"2","key":"3288_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/pan.13050","volume":"27","author":"JD Tobias","year":"2017","unstructured":"Tobias JD. Current evidence for the use of sugammadex in children. Paediatr Anaesth. 2017;27(2):118\u201325.","journal-title":"Paediatr Anaesth"},{"issue":"3","key":"3288_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/s-0040-1705133","volume":"9","author":"JD Tobias","year":"2020","unstructured":"Tobias JD. Sugammadex: Applications in Pediatric Critical Care. J Pediatr Intensive Care. 2020;9(3):162\u201371.","journal-title":"J Pediatr Intensive Care"},{"key":"3288_CR15","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000005386","author":"DJ Faulk","year":"2021","unstructured":"Faulk DJ, Austin TM, Thomas JJ, Strupp K, Macrae AW, Yaster M. A Survey of the Society for Pediatric Anesthesia on the Use, Monitoring, and Antagonism of Neuromuscular Blockade. Anesth Analg. 2021. https:\/\/doi.org\/10.1213\/ANE.0000000000005386.","journal-title":"Anesth Analg"},{"issue":"34","key":"3288_CR16","doi-asserted-by":"publisher","first-page":"e4678","DOI":"10.1097\/MD.0000000000004678","volume":"95","author":"YJ Won","year":"2016","unstructured":"Won YJ, Lim BG, Lee DK, Kim H, Kong MH, Lee IO. Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis. Medicine (Baltimore). 2016;95(34):e4678.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"3288_CR17","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1038\/s41598-017-06159-2","volume":"7","author":"G Liu","year":"2017","unstructured":"Liu G, Wang R, Yan Y, Fan L, Xue J, Wang T. The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review. Sci Rep. 2017;7(1):5724.","journal-title":"Sci Rep"},{"key":"3288_CR18","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"3288_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/00000542-199704000-00005","volume":"86","author":"AF Kopman","year":"1997","unstructured":"Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 1997;86:765\u201371.","journal-title":"Anesthesiology"},{"key":"3288_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for systematic reviews of interventions version 6.0","author":"JP Higgins","year":"2019","unstructured":"Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for systematic reviews of interventions version 6.0, vol. 4. 2019. p. 64\u201375."},{"issue":"2","key":"3288_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/ALN.0b013e318194caaa","volume":"110","author":"B Plaud","year":"2009","unstructured":"Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JH, et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology. 2009;110(2):284\u201394. https:\/\/doi.org\/10.1097\/ALN.0b013e318194caaa (PMID: 19194156).","journal-title":"Anesthesiology"},{"key":"3288_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00003643-201106001-00490","volume":"28","author":"R Veiga","year":"2011","unstructured":"Veiga R, Carceles B, Dominguez S, Lopez F, Orozco M, Alvarez-Gomez J. Sugammadex reversal efficacy and security vs neostigmine in the rocuronium-induced neuromuscular blockade in paediatric patients:10AP3-5. Eur J Anaesthesiol. 2011;28:153.","journal-title":"Eur J Anaesthesiol"},{"key":"3288_CR23","volume-title":"Efficacy and safety of the reversal with sugammadex from deep rocuronium-induced neuromuscular blockade in children","author":"JA Alvarez-Gomez","year":"2012","unstructured":"Alvarez-Gomez JA, Baron M, Ruiz GV, et al. Efficacy and safety of the reversal with sugammadex from deep rocuronium-induced neuromuscular blockade in children. 2012. (http:\/\/www.asaabstracts.com\/strands\/asaabstracts\/abstract.htm?year=2012&index=16&absnum=2981)."},{"issue":"S2","key":"3288_CR24","first-page":"308","volume":"108","author":"D Gaona","year":"2012","unstructured":"Gaona D, Carceles M, Veiga G, Lopez R, Mejia J, Asensi P. Efficacy and safety of the reversal with sugammadex in deep neuromuscular blockade induced by rocuronium in pediatrics. Br J Anaesth. 2012;108(S2):308\u20139.","journal-title":"Br J Anaesth"},{"issue":"6","key":"3288_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bjan.2014.03.001","volume":"64","author":"T Kara","year":"2014","unstructured":"Kara T, Ozbagriacik O, Turk HS, Isil CT, Gokuc O, Unsal O, et al. Sugammadex versus neostigmine in pediatric patients: a prospective randomized study. Rev Bras Anestesiol. 2014;64(6):400\u20135.","journal-title":"Rev Bras Anestesiol"},{"issue":"8","key":"3288_CR26","first-page":"762","volume":"19","author":"C Ozg\u00fcn","year":"2014","unstructured":"Ozg\u00fcn C, Cakan T, Baltac\u0131 B, Ba\u015far H. Comparison of reversal and adverse effects of sugammadex and combination of - Anticholinergic-Anticholinesterase agents in pediatric patients. J Res Med Sci. 2014;19(8):762\u20138.","journal-title":"J Res Med Sci"},{"issue":"3","key":"3288_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4103\/1658-354X.154696","volume":"9","author":"AA Ghoneim","year":"2015","unstructured":"Ghoneim AA, El Beltagy MA. Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients. Saudi J Anaesth. 2015;9(3):247\u201352.","journal-title":"Saudi J Anaesth"},{"issue":"4","key":"3288_CR28","first-page":"447","volume":"32","author":"M El Sayed","year":"2016","unstructured":"El Sayed M, Hassan S. Does sugammadex facilitate recovery after outpatient tonsillectomy in children? Egyt J Anesth. 2016;32(4):447\u201350.","journal-title":"Egyt J Anesth"},{"key":"3288_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4274\/haseki.3091","volume":"54","author":"D G\u00fczelce","year":"2016","unstructured":"G\u00fczelce D, Kendigelen P, T\u00fct\u00fcnc\u00fc A, Kaya G, Altintas F. Comparison of sugammadex and neostigmine in terms of time to extubation in pediatrics. Med Bull Haseki. 2016;54:207\u201311.","journal-title":"Med Bull Haseki"},{"key":"3288_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1213\/01.ane.0000492650.20862.e4","volume":"123","author":"RH Mohamad Zaini","year":"2016","unstructured":"Mohamad Zaini RH, Penny Tevaraj JM, Wan Hassan WN, et al. Comparison between the efficacy of neostigmine versus sugammadex for reversal of rocuronium induced neuromuscular blockade in paediatric patients. Anesth Analg. 2016;123:329.","journal-title":"Anesth Analg"},{"issue":"4","key":"3288_CR31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/aas.12868","volume":"61","author":"AS Ammar","year":"2017","unstructured":"Ammar AS, Mahmoud KM, Kasemy ZA. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children. Acta Anaesthesiol Scand. 2017;61(4):374\u201380.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"9","key":"3288_CR32","doi-asserted-by":"publisher","first-page":"907","DOI":"10.15537\/smj.2019.9.24485","volume":"40","author":"MO Korkmaz","year":"2019","unstructured":"Korkmaz MO, Sayhan H, Guven M. Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing adenotonsillectomy? Saudi Med J. 2019;40(9):907\u201313.","journal-title":"Saudi Med J"},{"issue":"3","key":"3288_CR33","doi-asserted-by":"publisher","first-page":"288","DOI":"10.17085\/apm.2019.14.3.288","volume":"14","author":"J An","year":"2019","unstructured":"An J, Lee JH, Kim E, Woo K, Kim H, Lee D. Comparison of sugammadex and pyridostigmine bromide for reversal of rocuronium-induced neuromuscular blockade in short-term pediatric surgery: a prospective randomized study. Anesthesia and Pain Medicine. 2019;14(3):288\u201393.","journal-title":"Anesthesia and Pain Medicine"},{"issue":"2","key":"3288_CR34","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.26452\/ijrps.v11i2.2335","volume":"11","author":"AA Hussein","year":"2020","unstructured":"Hussein AA, Hegazy MM, Elramely MA, Mohamed AG. Sugammadex versus neostigmine in pediatric cancer patients undergoing outpatient surgical procedures. Int J Res Pharm Sci. 2020;11(2):2741\u20136.","journal-title":"Int J Res Pharm Sci"},{"key":"3288_CR35","doi-asserted-by":"publisher","first-page":"110180","DOI":"10.1016\/j.biopha.2020.110180","volume":"127","author":"XB Li","year":"2020","unstructured":"Li XB, Jiang Y, Zhang WP, Zhang RF, Li J, Wei R. Effects of sugammadex on postoperative respiratory management in children with congenital heart disease: a randomized controlled study. Biomed Pharmacother. 2020;127:110180.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"3288_CR36","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1053\/j.jvca.2020.08.069","volume":"35","author":"L Li","year":"2021","unstructured":"Li L, Jiang Y, Zhang W. Sugammadex for Fast-Track Surgery in Children Undergoing Cardiac Surgery: A Randomized Controlled Study. J Cardiothorac Vasc Anesth. 2021;35(5):1388\u201392.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"6","key":"3288_CR37","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3760\/cma.j.cn321761-20190722-00049.Chinese","volume":"41","author":"J Hu","year":"2020","unstructured":"Hu J, Peng Z, Wang L, Zhang R, Bai J. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade undergoing laparoscopic inguinal hernia repair in children. Int J Anesth Resus. 2020;41(6):550\u20134. https:\/\/doi.org\/10.3760\/cma.j.cn321761-20190722-00049.Chinese.","journal-title":"Int J Anesth Resus"},{"key":"3288_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.13664\/j.cnki.pcr.2020.02.015.Chinese","volume":"02","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Wei R, Zhang R, Zheng J. Efficacy and safety of sugammadex in reversing rocuronium-induced neuromuscular blockade in children post elective tonsillectomy. Pharm Clin Res. 2020;02:139\u201341. https:\/\/doi.org\/10.13664\/j.cnki.pcr.2020.02.015.Chinese.","journal-title":"Pharm Clin Res"},{"key":"3288_CR39","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Sch\u00fcnemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64:380\u20132.","journal-title":"J Clin Epidemiol"},{"key":"3288_CR40","doi-asserted-by":"publisher","first-page":"h1354","DOI":"10.1136\/bmj.h1354","volume":"350","author":"LB Holst","year":"2015","unstructured":"Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ. 2015;350:h1354.","journal-title":"BMJ"},{"issue":"2","key":"3288_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: a simple funnel-plot\u2013based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455\u201363.","journal-title":"Biometrics"},{"issue":"3","key":"3288_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bpa.2005.03.001","volume":"19","author":"CC Apfel","year":"2005","unstructured":"Apfel CC, Stoecklein K, Lipfert P. PONV: a problem of inhalational anaesthesia? Best Pract Res Clin Anaesthesiol. 2005;19(3):485\u2013500.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"4","key":"3288_CR43","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1213\/ANE.0000000000004207","volume":"129","author":"RS Gaver","year":"2019","unstructured":"Gaver RS, Brenn BR, Gartley A, Donahue BS. Retrospective analysis of the safety and efficacy of sugammadex versus neostigmine for the reversal of neuromuscular blockade in children. Anesth Analg. 2019;129(4):1124\u20139.","journal-title":"Anesth Analg"},{"issue":"4","key":"3288_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/096228020101000402","volume":"10","author":"JB Copas","year":"2001","unstructured":"Copas JB, Shi JQ. A sensitivity analysis for publication bias in systematic reviews. Stat Methods Med Res. 2001;10(4):251\u201365.","journal-title":"Stat Methods Med Res"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03288-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03288-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03288-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T06:04:45Z","timestamp":1652940285000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03288-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3288"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03288-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"19 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"295"}}